FRANCO, RENATO
 Distribuzione geografica
Continente #
NA - Nord America 242
EU - Europa 177
AS - Asia 90
AF - Africa 12
Totale 521
Nazione #
US - Stati Uniti d'America 238
IT - Italia 92
CN - Cina 44
SG - Singapore 40
NL - Olanda 26
IE - Irlanda 19
CI - Costa d'Avorio 12
FI - Finlandia 11
DE - Germania 10
UA - Ucraina 10
CA - Canada 4
GB - Regno Unito 4
VN - Vietnam 4
FR - Francia 2
ES - Italia 1
IN - India 1
RO - Romania 1
SI - Slovenia 1
TR - Turchia 1
Totale 521
Città #
Chandler 57
Singapore 36
Amsterdam 26
Naples 25
Napoli 22
Ashburn 20
Beijing 14
Princeton 12
Millbury 10
Nanjing 10
Jacksonville 9
Des Moines 8
Bologna 6
Munich 6
Santa Clara 6
Boston 5
Hebei 5
Helsinki 5
Caserta 4
Dong Ket 4
Nanchang 4
Ottawa 4
Shanghai 3
Shenyang 3
Wilmington 3
Kronberg 2
New York 2
Nola 2
Somma Vesuviana 2
Villanovafranca 2
Boardman 1
Cricklewood 1
Dallas 1
Dearborn 1
Dublin 1
Ercolano 1
Falls Church 1
Genova 1
Guangzhou 1
Horia 1
Jiaxing 1
Jinan 1
Kunming 1
Lanzhou 1
London 1
Orange 1
Rome 1
San Giorgio Del Sannio 1
Sant'arpino 1
Totale 336
Nome #
Mitochondrial AKAP1 supports mTOR pathway and tumor growth 82
Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy? 61
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 54
High levels of GPR30 protein in human testicular carcinoma in situ and seminomas correlate with low levels of estrogen receptor-beta and indicate a switch in estrogen responsiveness 47
CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression 46
Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression. 45
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 43
The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma 41
Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma 37
Glucose impairs tamoxifen responsiveness modulating connective tissue growth factor in breast cancer cells 35
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC 34
Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors 29
Totale 554
Categoria #
all - tutte 2.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.412


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 0 0 0 0 8 0 3 1 0 6 13 3
2020/202136 1 3 5 2 2 2 2 1 8 4 2 4
2021/202290 0 0 1 0 0 2 0 3 20 10 30 24
2022/2023128 12 7 4 12 21 17 0 7 19 24 5 0
2023/202499 4 14 24 10 4 4 3 16 1 6 10 3
2024/202562 17 20 1 4 20 0 0 0 0 0 0 0
Totale 554